Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email in the first instance.

 Information  X 
Enter a valid email address

Oxford Instruments (OXIG)

  Print      Mail a friend

Tuesday 21 September, 2004

Oxford Instruments

AGM Statement

Oxford Instruments PLC
21 September 2004

21 September 2004
                             Oxford Instruments plc
                               AGM Trading Update

Oxford Instruments plc will be holding its Annual General Meeting today, at
which the Chairman, Nigel Keen, will make the following statement:

Business Strategy and Focus

Oxford Instruments has made a successful return to consistent profitability
through a series of internal programmes designed to create a stable and
cost-effective operational base. While we will continue to drive hard for
further operational improvements, we are reviewing our business, taking into
account both the investment opportunities and our focus on improving shareholder

Our technology strengths are widely acknowledged. However, we are most
successful in creating value when we develop a deep understanding of our
end-user customer requirements and then use our technology to deliver
differentiated technology-based solutions through a cost-effective organisation.
This defines our focus towards two key areas of the business:

Firstly, we need to grow our product lines where we are already supplying
complete solutions and services to customers who have materials processing and
measurement problems. In particular, we are looking to expand our solutions
business in the customer segments of life sciences, nanotechnology and
industrial and environmental quality control. We announced last week the
acquisition of Metorex International Oy, a business specialising in industrial
chemical analysis. We also announce today the acquisition of Resonance
Instruments, a leading supplier of advanced industrial quality control

Secondly, we will continue to grow our key components businesses in areas where
they support our solutions strategy. For example, the acquisition of Metorex
International Oy gives us proprietary technology for X-ray detectors, a key
component in our X-ray based measurement products.

Acquisition of Resonance Instruments Limited

We announce today that we have completed the acquisition of the entire share
capital of Resonance Instruments Limited ("Resonance").

Resonance, a privately owned company established twelve years ago which is based
in Witney, Oxfordshire, is a market leader in instruments for quality control
and research applications using low resolution nuclear magnetic resonance
("NMR"). It also supplies components and subsystems for research applications of
magnetic resonance imaging ("MRI").

We have made an initial payment on completion of £1.8m. The total consideration
payable for the shares of Resonance will be a maximum of £3.0m in cash. The
annual management accounts of Resonance for the year to 30 September 2003
reported sales of £2.7m and an operating loss of less than £0.1m. Net assets
acquired at completion are estimated to be £0.2m. The acquisition is expected to
be slightly earnings enhancing in 2004/05, with a growing contribution in 2005/
06 and beyond.

By acquiring Resonance, we will strengthen our existing range of bench-top, low
resolution NMR products and we will also acquire important complementary skills
to enhance our development of novel sample preparation techniques for the life
sciences market, using technology licensed earlier this year from GE Healthcare.

Current Trading

Total order levels for the first half are expected to be close to internal
forecasts. We have previously stated that volumes in the Superconductivity
business will be well down on last year and as forecast the magnet inventory
reduction programme by Varian, a magnet customer, has held back magnet shipments
in the first half.

We have now regained control over the quality problems previously reported in
the supply base of our wire business, which affected one specific product used
only by Siemens. We expect to take an exceptional charge not exceeding £1.7m
associated with this in the first half.

As indicated at the time of our preliminary results in June, turnover and hence
pre-tax profits in the first half for continuing operations before goodwill and
before exceptional items will be below the same period last year. However, our
current review indicates that the outcome for the full year is expected to be in
line with market expectations.

Oxford Instruments plc                                   01865 881437
Andrew Mackintosh, Chief Executive
Martin Lamaison, Finance Director

Hogarth Partnership Limited                              020 7357 9477
Andrew Jaques
Rachel Hirst

Notes to editors

Oxford Instruments plc

Oxford Instruments is a global leader in advanced instrumentation. It is a
recognised world leader in several technologies, including the application of
superconductivity, the creation of low temperatures, the production and
detection of X-rays and in neurological measurements. The Company's products are
used around the world in scientific research, industrial chemical analysis and
quality control, healthcare and semiconductor processing. Its customers include
most of the world's major international companies, as well as the leading
hospitals and research institutes.

Born out of Oxford University, with over 40 years of continuous product
development, Oxford Instruments today comprises three businesses: Analytical,
Medical and Superconductivity.

                      This information is provided by RNS
            The company news service from the London Stock Exchange